Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of tralokinumab in inadequately controlled asthma
jRCT2080222698Phase 3
- Sponsor
- AstraZeneca
- Start
- Dec 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Tralokinumab with Placebo (2 arms).
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080222698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222698.